Some of the main grievances the authors laid out were the White House’s announcement that it might block the FDA from issuing scientific guidance on vaccine approval; HHS Secretary Alex Azar’s Sept. 15 renouncement of the agency’s authority to create safety rules; and the White House’s overruling of FDA scientists’ decision on COVID-19 tests.
The former commissioners acknowledged the “integrity and high-quality scientific work of FDA staff” and the agency’s commitment to adhere to strict standards for vaccine approval, but expressed concern that the perception of political influence is causing Americans to lose trust in the agency. The letter pointed out that September’s Axios-Ipsos poll results found that 42 percent of Americans lacked trust in the FDA’s ability to make reliable decisions.
“The implications of the recent shift are potentially dire,” the former FDA commissioners wrote. “When the FDA warns about a risk from contaminated food, will people heed it? When a new drug for cancer or heart disease is approved, will clinicians and families trust it to work? And most urgent for today: When the FDA approves a covid-19 vaccine, will Americans accept it?”
They concluded their column by writing, “Political intrusion only prolongs the pandemic and erodes our public health institutions.”
More articles on pharmacy:
Regeneron COVID-19 antibody drug helps patients recover faster in early trials
Pfizer to give $22M in drugs to Strategic National Stockpile
10 recent exec moves affecting the pharma industry
